drugset / Trial / NCT01292304
Tolvaptan for Ascites in Cirrhotic Patients
NaSingle-groupOpen-labelTreatment
Summary
Open Label Study evaluating the safety and efficacy of tolvaptan in the treatment of ascites in liver cirrhosis. Tolvaptan will be administered in combination with current ascites management.
Timeline
- Start
- 2012-03
- Primary completion
- 2014-12
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tolvaptan | Small molecule | 30 mg | Oral |